Robert C. Murphy, M.D., Ph.D.

  1. Radiologist
  1. Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. (18)F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker. J Nucl Med. 2018 May; 59 (5):774-779 Epub 2017 Nov 02
    View PubMed
  2. Lehman VT, Murphy RC, Schenck LA, Carter RE, Johnson GB, Kotsenas AL, Morris JM, Nathan MA, Wald JT, Maus TP. Comparison of facet joint activity on 99mTc-MDP SPECT/CT with facet joint signal change on MRI with fat suppression. Diagn Interv Radiol. 2016 May-Jun; 22 (3):277-83
    View PubMed
  3. Welle CL, Cullen EL, Peller PJ, Lowe VJ, Murphy RC, Johnson GB, Binkovitz LA. (1)(1)C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes. Radiographics. 2016 Jan-Feb; 36 (1):279-92
    View PubMed
  4. Crush AB, Howe BM, Spinner RJ, Amrami KK, Hunt CH, Johnson GB, Murphy RC, Morreale RF, Peller PJ. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation. Radiographics. 2014 Nov-Dec; 34 (7):1987-2007
    View PubMed
  5. Lehman VT, Murphy RC, Kaufmann TJ, Diehn FE, Murthy NS, Wald JT, Thielen KR, Amrami KK, Morris JM, Maus TP. Frequency of discordance between facet joint activity on technetium Tc99m methylene diphosphonate SPECT/CT and selection for percutaneous treatment at a large multispecialty institution. AJNR Am J Neuroradiol. 2014 Mar; 35 (3):609-14 Epub 2013 Sept 12
    View PubMed
  6. Kitajima K, Murphy RC, Nathan MA, Froemming AT, Hagen CE, Takahashi N, Kawashima A. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. J Nucl Med. 2014 Feb; 55 (2):223-32 Epub 2014 Jan 16
    View PubMed
  7. Kitajima K, Murphy RC, Nathan MA, Sugimura K. Update on positron emission tomography for imaging of prostate cancer. Int J Urol. 2014 Jan; 21: (1)12-23.
    View PubMed
  8. Lehman VT, Murphy RC, Maus TP. 99mTc-MDP SPECT/CT of the spine and sacrum at a multispecialty institution: clinical use, findings, and impact on patient management. Nucl Med Commun. 2013 Nov; 34: (11)1097-106.
    View PubMed
  9. Kitajima K, Murphy RC, Nathan MA. Choline PETCT for imaging prostate cancer: an update. Ann Nucl Med. 2013 Aug; 27: (7)581-91.
    View PubMed
  10. O'Toole O, Murphy R, Tracy JA, McKeon A. Teaching NeuroImages: PET-CT hypermetabolism paralleling muscle hyperactivity in stiff-person syndrome. Neurology. 2013 Mar 05; 80: (10)e109.
    View PubMed
  11. Lehman VT, Carter RE, Claassen DO, Murphy RC, Lowe V, Petersen RC, Peller PJ. Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease. Clin Nucl Med. 2012 Aug; 37: (8)721-6.
    View PubMed
  12. Gleeson F, Clapp A, Murphy R, Clain J, Iyer P, Rajan E, Topazian M, Wang K, Levy M. EUS FNA of Altered Left Adrenal Gland Morphology Suggests Amending CT and PET-CT Attenuation Threshold Values That Predict Malignancy JCT. 2012; 3(No. 6):1029-36.
  13. Murphy RC, Kawashima A, Peller PJ. The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide. AJR Am J Roentgenol. 2011 Jun; 196: (6)1390-8.
    View PubMed
  14. Murphy R, Doerger KM, Nathan MA, Lowe VJ. Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis. Mol Imaging Biol. 2009 Mar-Apr; 11 (2):114-7 Epub 2008 Nov 27
    View PubMed
  15. York JD, Odom AR, Murphy R, Ives EB, Wente SR. A Phospholipase C-dependent Inositol Polyphosphate Kinase Pathway Required for Efficient Messenger RNA Export. Science. 1999; 285:96-100.
  16. Watkins JL, Murphy R, Emtage JL, Wente SR. The human homologue of Saccharomyces cereviciae Gle1p is required for poly(A)+ RNA export. PNAS USA. 1998; 95:6779-84.
  17. Murphy R, Watkins JL, Wente SR. GLE2, a Saccharomyces cerevisiae homologue of the Schizosaccharomyces pombe export factor RAE1, is required for nuclear pore complex structure and function. Mol Biol Cell. 1996 Dec; 7: (12)1921-37.
    View PubMed
  18. Murphy R, Wente SR. An RNA-export mediator with an essential nuclear export signal. Nature. 1996 Sep 26; 383: (6598)357-60.
    View PubMed